Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236,234,693
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
7,115,554
-
Shares change
-
-70,452
-
Total reported value, excl. options
-
$82,816,339
-
Value change
-
-$6,653,680
-
Number of buys
-
30
-
Number of sells
-
21
-
Price
-
$11.64
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q4 2014
As of 31 Dec 2014 Akebia Therapeutics, Inc. - Common Stock (AKBA) had 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,115,554 shares of stock of the company.
Largest 10 holders included Novo A/S, EAGLE ASSET MANAGEMENT INC, HealthCor Management, L.P., FMR LLC, RA CAPITAL MANAGEMENT, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, BALYASNY ASSET MANAGEMENT LLC, MORGAN STANLEY, and Cormorant Asset Management, LLC.
This table shows 55 institutional shareholders of the security as of 31 Dec 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.